No headlines found.
No press releases found.
No news found.
The NVO 2x Daily ETF (the "Fund") is an actively managed exchange-traded fund that, under ordinary market conditions, seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of Novo Nordisk A/S ("NVO"). Under normal circumstances, the Fund will invest at least 80% of the value of its net assets, plus any borrowings for investment purposes, in financial instruments (for example, swaps and futures) that, in the aggregate, provide leveraged exposure to the Underlying Security equal to approximately two times its daily performance. Novo Nordisk A/S (NYSE: NVO) ("Novo Nordisk") is a Denmark-based pharmaceutical company engaged in the research, development, manufacture, and sale of medicines, including treatments for diabetes, obesity, and other serious chronic diseases. Novo Nordisk operates globally and is headquartered in Bagsvrd, Denmark.
Corgi Nvo 2X Daily ETF trades on the BATS stock market under the symbol NVOC.
As of September 9, 2026, NVOC stock price was flat at $20.58 with 13 million shares trading.
NVOC has a market cap of $308,698.00. This is considered a Sub-Micro Cap stock.
NVOC support price is $19.80 and resistance is $21.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVOC shares will trade within this expected range on the day.
